alexa Hemolytic Disease of the Newborn

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Global Summit On Oncology and Breast Cancer

Vienna, Austria

Health and Medical Tourism 2020

Dubai, UAE

Global Summit on Oncology and Cancer Therapy

New York, USA
Hemolytic Disease of the Newborn

Hemolytic disease of the newborn (HDN), with high potential for increased fetal loss is less common now, due to the universal screening for iso-sensitization and also because of appropriate use of antenatal anti-RhD antibody prophylaxis. There are other non-RhD antibodies that can cause HDN. In US, we occasionally encounter a highly sensitized fetus with significant morbidity and mortality.



Citation: Nandyal RR (2015) Hemolytic Disease of the Newborn. J Hematol Thrombo Dis 3:203. doi: 10.4172/2329-8790.1000203

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger